news

« BACK

University of Italian Switzerland


Results 41 - 52 of 52.


Life Sciences - Health - 31.10.2019
With a new Artificial Intelligence method, humans and machines can analyse complex biomedical data
An interdisciplinary team of researchers from the USI Institute of Computational Sciences (ICS), and the Institute for Research in Biomedicine (IRB), affiliated to USI, have developed a new Artificial Intelligence method that enables the analysis of complex biomedical data. The results of the research have been published in the renowned scientific journal Science advances .

Life Sciences - Computer Science - 14.10.2019
"Virtual microscopes" freely accessible, thanks to USI’s contribution
Molecular dynamics simulations represent an increasingly important cornerstone of modern scientific research, thanks to their unparalleled ability to meticulously describe fundamental aspects of complex systems. It is not a coincidence that nowadays molecular simulations are considered a "virtual microscope" from which admire and examine biological processes, as well as confirm through "computational assays" innovative hypotheses which provide the basis for designing new experiments.

Environment - Health - 07.10.2019
The impact of ambient air pollution on hospital admissions
Air pollution is the centre of debate on many fronts, from air protection measures involving road traffic, to technological innovations to reduce harmful emissions.

Physics - 19.09.2019
Quantum physics: beyond the logic of cause and effect
In classical, Newtonian theory, causality, the connection between cause and effect, is considered to sit at the core of physics: Causal thinking, together with the idea that absolute time and space are the pre-given stage for all physical events, have been dominating classical physics well into the twentieth century.

Pharmacology - Health - 10.09.2019
Multiple sclerosis therapy: scientists identify the Achilles' heel of a therapeutic antibody and find a solution to avoid the problem
Multiple sclerosis therapy: scientists identify the Achilles’ heel of a therapeutic antibody and find a solution to avoid the problem
An international research team led by the Institute for Research in Biomedicine, affiliated to the Università della Svizzera italiana, has discovered why some patients with multiple sclerosis make an immune reaction that curtails the effectiveness of natalizumab, a therapeutic antibody used for the treatment of the disease and used this information to engineer a new version of the antibody that avoids this problem.

Pharmacology - Health - 05.08.2019
Future clinical studies in lymphoma patients
At the Institute of Oncology Research (IOR, affiliated to USI), researchers have discovered two molecules, so far known in the field of treatments against Ewing's sarcoma, which have strong antilymphoma activity, thus proposing clinical studies on patients. The study has been published in the scientific journal Clinical Cancer Research .

Social Sciences - Health - 17.06.2019
Social Exclusion Measured in fMRI
Social Exclusion Measured in fMRI
A fMRI study shows the effect of social support on the social exclusion experience. Social belonging is a fundamental need for the life of human beings.

Health - Life Sciences - 23.05.2019
New way to eliminate cancer stem cells in prostate cancer
New way to eliminate cancer stem cells in prostate cancer
Tumor stem cells from prostate cancer. The coloring with different fluorochromes highlights the extensive network of mitochondria (red/green) surrounding the cell nuclei (blue). A study by investigators at the Institute of Oncology Research (IOR, affiliated to USI Università della Svizzera italiana) reveals a new way to eliminate cancer stem cells (CSC) in prostate tumours and enhance treatment efficacy.

Astronomy / Space Science - Physics - 29.04.2019
Positive outcome from the CLASP-II solar physics experiment that involved IRSOL
Positive outcome from the CLASP-II solar physics experiment that involved IRSOL
Some of the CLASP-II scientists pose for a photograph in front of the rocket at White Sands Missile Range (New Mexico, USA) (image: U.S. Army, Louis Rosales) On April 11, 2019, at the NASA facility at the White Sands Missile Range in New Mexico (USA), the successful launch of a sounding rocket was performed as part of the "Chromospheric LAyer Spectro-Polarimeter" experiment (CLASP-II).

Administration - 25.03.2019
New perspectives in tax competition: the rise of tax havens in Switzerland
New perspectives in tax competition: the rise of tax havens in Switzerland
How do local tax havens emerge? Is tax competition harmful? Raphaël Parchet, Assistant professor at the Faculty of Economics of Università della Svizzera italiana, addresses these questions in his new project "Sorting, Tax Competition and the Rise of Local Tax Havens", funded by the Swiss National Science Foundation (SNSF), shedding new light on the logic behind the rise of tax havens in Switzerland.

Health - 08.03.2019
IRB research provides new hope against bronchiolitis
IRB research provides new hope against bronchiolitis
A collaborative project between the Institute for Research in Biomedicine (IRB, affiliated to USI) and several other European and American research institutes provides new hope for the development of an efficient vaccine against human Respiratory Syncytial Virus (hRSV), which is responsible, in particular, for acute lung infections such as bronchiolitis in children.

Health - Pharmacology - 25.01.2019
Promising results in the fight against Ebola
Promising results in the fight against Ebola
A Phase 1 clinical trial to test the safety of an antibody to use against Ebola outbreak has been successfully concluded by the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland (U.S.A. The treatment is based on the monoclonal antibody mAb114, which was isolated and characterized in Switzerland at the Institute for Research in Biomedicine (IRB Bellinzona, affiliated to USI Università della Svizzera italiana) in collaboration with Humabs BioMed SA, a subsidiary of Vir Biotechnology Inc.

This site uses cookies and analysis tools to improve the usability of the site. More information. |